drugset / Trial / NCT04675151

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

NCT04675151

Phase 2 Completed 150 enrolled Ocuphire Pharma, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia

Timeline

Start
2021-02-15
Primary completion
2021-05-17
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule 0.75 % Other
Subject Pilocarpine Unknown Other

Indications